Earlier research showed mutations in the β2M gene in CRC and revealed that β2M mutations were remarkably related to the MSI phenotype and had a lower prevalence in microsatellite stable (MSS) tumours (42, 43). This evidence concerns the gene B2M and colorectal carcinoma.